Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

The extracellular matrix affects where tumors can start in the body.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Targeting Vδ1+T-cells may help treat alopecia areata.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

HIV can cause unusual and severe skin problems that are hard to treat.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

A gene deletion in mice causes weak protein, immune issues, hair loss, airway problems, and wasting disease.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

CD4+ skin cells may be precursors to basal cell carcinoma.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.